Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Richard B. Zelman
Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
JAMA - Journal of the American Medical Association
Medicine
Related publications
Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
JAMA - Journal of the American Medical Association
Medicine
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
ACC Current Journal Review
Glycoprotein IIb/IIIa Induced Coronary Thrombolysis
Heart
Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non-St-Elevation Acute Coronary Syndromes
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Off-Target Effects of Glycoprotein IIb/IIIa Receptor Inhibitors
Cardiology Journal
Medicine
Cardiovascular Medicine
Cardiology
Current Evidence for the Use of Platelet Gpiib/Iiia Receptor Inhibitors in Acute Coronary Syndromes
The Internet Journal of Anesthesiology
Infarct Angioplasty: Beyond Stents and Glycoprotein IIb/IIIa Inhibitors
Heart
Cardiovascular Medicine
Cardiology
Platelet Inhibition After Glycoprotein IIb/IIIa Inhibitor Therapy
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Deaths Associated With Platelet Glycoprotein IIb/IIIa Inhibitor Treatment
Heart